A V Alessenko
Overview
Explore the profile of A V Alessenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alessenko A, Gutner U, Nebogatikov V, Shupik M, Ustyugov A
Zh Nevrol Psikhiatr Im S S Korsakova
. 2021 Sep;
121(8):131-140.
PMID: 34481449
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by selective degeneration of motor neurons of the spinal cord and motor cortex and brain stem. The key features of...
2.
Alessenko A, Gutner U, Nebogatikov V, Shupik M, Ustyugov A
Zh Nevrol Psikhiatr Im S S Korsakova
. 2020 Nov;
120(10):108-117.
PMID: 33244966
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease characterized by selective degeneration of motor neurons of the motor cortex, brain stem and brain stem. Mutations in genes coding for...
3.
Gutner U, Shupik M, Maloshitskaya O, Sokolov S, Rezvykh A, Funikov S, et al.
Biochemistry (Mosc)
. 2019 Nov;
84(10):1166-1176.
PMID: 31694512
The aim of this study was to evaluate changes in the content of sphingoid bases - sphingosine (SPH), sphinganine, and sphingosine-1-phosphate (SPH-1-P) - and in expression of genes encoding enzymes...
4.
Alessenko A, Zateyshchikov D, Lebedev A, Kurochkin I
Kardiologiia
. 2019 Aug;
59(8):77-87.
PMID: 31397233
Lipid metabolism disorders are the most significant risk factor of development of cardiovascular diseases (CVD). In the process of diagnosing ischemic heart disease and other cardiovascular pathologies, levels of total...
5.
Alessenko A, Lebedev A, Kurochkin I
Biomed Khim
. 2019 Jan;
64(6):487-495.
PMID: 30632976
Cardiovascular diseases (CVD) remain the leading cause of death in industrialized countries. One of the most significant risk factors for atherosclerosis is hypercholesterolemia. Its diagnostics is based on routine lipid...
6.
Alessenko A, Bachurin S, Karatasso Y, Korotaeva A, Shevzova E, Shingarova L
Zh Nevrol Psikhiatr Im S S Korsakova
. 2018 Sep;
118(8):91-97.
PMID: 30251985
Aim: To investigate the ability of the neuroprotector dimebon to prevent alterations in brain lipid metabolism caused byTNF-α. Material And Methods: The ability of dimebon (2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride) to prevent alterations...
7.
Alessenko A, Bachurin S, Gurianova S, Karatasso Y, Shevtsova E, Shingarova L
Biomed Khim
. 2016 Aug;
62(4):418-25.
PMID: 27562995
Dimebon (Dimebolin) is an antihistamine drug which has been used in Russia since 1983. Recently Dimebolin has attracted renewed interest after being shown to have positive effects on persons suffering...
8.
Shupik M, Vanin A, Alessenko A
Biochemistry (Mosc)
. 2011 Nov;
76(11):1197-209.
PMID: 22117546
This review discusses the functional role of nitric oxide in ischemia-reperfusion injury and mechanisms of signal transduction of apoptosis, which accompanies ischemic damage to organs and tissues. On induction of...
9.
Dudnik L, Tsupko A, Shupik M, Akhaladze G, Galperin E, Latonova L, et al.
Bull Exp Biol Med
. 2008 Nov;
145(1):33-6.
PMID: 19023996
Restoration of bile flow after 9-day cholestasis in rat liver normalized the content of lipid peroxidation products. The removal of the cholestatic factor after 12-day cholestasis was not followed by...
10.
Alessenko A, Shupik M, Bugrova A, Dudnik L, Shingarova L, Mikoyan A, et al.
FEBS Lett
. 2005 Oct;
579(25):5571-6.
PMID: 16225875
We used animal models to study connection between oxidating system and sphingomyelin signaling cascade, because this models are more close related to people disease. Activation of n-sphingomyelinase (n-SMase) in mice...